| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |